[
    [
        {
            "time": "",
            "original_text": "华熙生物(688363)2020年中报点评：业绩修复中 护肤品引领高速增长",
            "features": {
                "keywords": [
                    "华熙生物",
                    "中报",
                    "业绩修复",
                    "护肤品",
                    "高速增长"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物科技",
                    "护肤"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "华熙生物(688363)2020年中报点评：业绩修复中 护肤品引领高速增长",
                "Correlation": 9,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 5
            }
        },
        {
            "time": "",
            "original_text": "华熙生物上半年实现营收9.47亿元 疫情冲击下业绩逆势增长",
            "features": {
                "keywords": [
                    "华熙生物",
                    "上半年",
                    "营收",
                    "疫情",
                    "逆势增长"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "华熙生物上半年实现营收9.47亿元 疫情冲击下业绩逆势增长",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 6,
                "Headline_Structure": 9,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "华熙生物(688363)：功能性护肤持续爆发 销售费用大幅提升拖累业绩 盈利能力下降",
            "features": {
                "keywords": [
                    "华熙生物",
                    "功能性护肤",
                    "销售费用",
                    "盈利能力下降"
                ],
                "sentiment_score": -0.5,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物科技",
                    "护肤"
                ],
                "causal_factor": "true",
                "causal_impact": "negative",
                "affected_by_time_series": "true",
                "ts_effect_direction": "negative"
            },
            "scores": {
                "News_content": "华熙生物(688363)：功能性护肤持续爆发 销售费用大幅提升拖累业绩 盈利能力下降",
                "Correlation": 10,
                "Sentiment": 5,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 5,
                "Headline_Structure": 9,
                "Source_Recency": 5
            }
        },
        {
            "time": "",
            "original_text": "社保基金持有科创板股清单：新建仓8股，增持3只",
            "features": {
                "keywords": [
                    "社保基金",
                    "科创板",
                    "新建仓",
                    "增持"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "社保基金持有科创板股清单：新建仓8股，增持3只",
                "Correlation": 6,
                "Sentiment": 6,
                "Importance": 7,
                "Impact": 5,
                "Duration": 5,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "受益功能性护肤品业务，华熙生物2020年上半年营收同比增17.05%",
            "features": {
                "keywords": [
                    "华熙生物",
                    "功能性护肤品",
                    "营收增长"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物科技",
                    "护肤"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "受益功能性护肤品业务，华熙生物2020年上半年营收同比增17.05%",
                "Correlation": 10,
                "Sentiment": 8,
                "Importance": 9,
                "Impact": 8,
                "Duration": 7,
                "Entity_Density": 10,
                "Market_Scope": 3,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 5
            }
        },
        {
            "time": "",
            "original_text": "【国信零售|中报点评】华熙生物：护肤品保持高增长，卡位优质赛道前景广阔",
            "features": {
                "keywords": [
                    "华熙生物",
                    "护肤品",
                    "高增长",
                    "优质赛道",
                    "前景广阔"
                ],
                "sentiment_score": 0.9,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "生物科技",
                    "护肤"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "false",
                "ts_effect_direction": ""
            },
            "scores": {
                "News_content": "【国信零售|中报点评】华熙生物：护肤品保持高增长，卡位优质赛道前景广阔",
                "Correlation": 9,
                "Sentiment": 8,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 9,
                "Market_Scope": 4,
                "Time_Proximity": 5,
                "Headline_Structure": 9,
                "Source_Recency": 5
            }
        }
    ]
]